标题
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
作者
关键词
-
出版物
ACS Central Science
Volume 7, Issue 4, Pages 512-533
出版商
American Chemical Society (ACS)
发表日期
2021-03-29
DOI
10.1021/acscentsci.1c00120
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice
- (2021) Abigail E. Powell et al. ACS Central Science
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial
- (2021) Peter Richmond et al. LANCET
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques
- (2021) Pragya D. Yadav et al. Nature Communications
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
- (2020) Shuai Xia et al. Cellular & Molecular Immunology
- Safety, immunogenicity and risk–benefit analysis of rVSV-ΔG-ZEBOV-GP (V920) Ebola vaccine in Phase I–III clinical trials across regions
- (2020) Bache Emmanuel Bache et al. Future Microbiology
- The promise of mRNA vaccines: a biotech and industrial perspective
- (2020) Nicholas A. C. Jackson et al. npj Vaccines
- Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
- (2020) Mihai G. Netea et al. CELL
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- The 3Ds in virus-like particle based-vaccines: “Design, Delivery and Dynamics ”
- (2020) Mona O. Mohsen et al. IMMUNOLOGICAL REVIEWS
- Development of an inactivated vaccine candidate for SARS-CoV-2
- (2020) Qiang Gao et al. SCIENCE
- Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
- (2020) Yuan Huang et al. ACTA PHARMACOLOGICA SINICA
- The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
- (2020) Qianqian Li et al. CELL
- A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
- (2020) Lianpan Dai et al. CELL
- A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
- (2020) Dorottya Laczkó et al. IMMUNITY
- Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients
- (2020) Linnan Zhu et al. IMMUNITY
- Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID‐19 deaths in Italy
- (2020) Daniela Marín‐Hernández et al. JOURNAL OF MEDICAL VIROLOGY
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19
- (2020) Mohamed Labib Salem et al. MEDICAL HYPOTHESES
- A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
- (2020) Jingyun Yang et al. NATURE
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
- (2020) Noe B. Mercado et al. NATURE
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
- (2020) Kizzmekia S. Corbett et al. NATURE
- ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
- (2020) Neeltje van Doremalen et al. NATURE
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
- (2020) Kizzmekia S. Corbett et al. NEW ENGLAND JOURNAL OF MEDICINE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)
- (2020) Luis E. Escobar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
- (2020) Divij Mathew et al. SCIENCE
- Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality
- (2020) Deus Thindwa et al. VACCINE
- Silver lining of COVID-19: Heightened global interest in pneumococcal and influenza vaccines, an infodemiology study
- (2020) Joseph Alexander Paguio et al. VACCINE
- Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
- (2020) Paul F. McKay et al. Nature Communications
- Principles Learned from the International Race to Develop a Safe and Effective COVID-19 Vaccine
- (2020) Ariel H. Thames et al. ACS Central Science
- Does Early Childhood Vaccination Protect Against COVID-19?
- (2020) Karzan R. Sidiq et al. Frontiers in Molecular Biosciences
- Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains
- (2020) Eriko Padron-Regalado Infectious Diseases and Therapy
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
- (2020) Carolyn Rydyznski Moderbacher et al. CELL
- Small molecule agonists of toll-like receptors 7 and 8: a patent review 2014 – 2020
- (2020) Madeleine E. Kieffer et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- Whither COVID-19 vaccines?
- (2020) Laura DeFrancesco NATURE BIOTECHNOLOGY
- Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters
- (2020) Lisa H. Tostanoski et al. NATURE MEDICINE
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
- (2020) Sandhya Bangaru et al. SCIENCE
- A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge
- (2020) Shipo Wu et al. Nature Communications
- A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone
- (2020) Baoshan Zhang et al. Scientific Reports
- Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
- (2020) Rinke Bos et al. npj Vaccines
- Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants
- (2020) Sören Reinke et al. Vaccines
- Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
- (2020) Allison J. Greaney et al. Cell Host & Microbe
- Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
- (2020) Xiancai Ma et al. IMMUNITY
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Eliciting B cell immunity against infectious diseases using nanovaccines
- (2020) Ankur Singh Nature Nanotechnology
- Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
- (2020) Alicia T. Widge et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emergence of a Highly Fit SARS-CoV-2 Variant
- (2020) Ralph S. Baric NEW ENGLAND JOURNAL OF MEDICINE
- ‘Absolutely remarkable’: No one who got Moderna’s vaccine in trial developed severe COVID-19
- (2020) Jon Cohen SCIENCE
- Covid-19: New coronavirus variant is identified in UK
- (2020) Jacqui Wise BMJ-British Medical Journal
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2020) Yanjun Zhang et al. LANCET INFECTIOUS DISEASES
- What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2
- (2020) Susanne H Hodgson et al. LANCET INFECTIOUS DISEASES
- Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
- (2019) Kimberly J. Hassett et al. Molecular Therapy-Nucleic Acids
- Lipid nanocarriers for microRNA delivery
- (2019) Marcel Scheideler et al. CHEMISTRY AND PHYSICS OF LIPIDS
- A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates
- (2018) Staci Sabnis et al. MOLECULAR THERAPY
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles
- (2018) Marianna Yanez Arteta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA
- (2018) Kirtika H. Asrani et al. RNA Biology
- Heterologous prime–boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus
- (2018) Seo-Yeon Jung et al. VACCINE
- New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue
- (2018) Karl D. Brune et al. Frontiers in Immunology
- mRNA cap regulation in mammalian cell function and fate
- (2018) Alison Galloway et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- N1-methyl-pseudouridine in mRNA enhances translation through eIF2α-dependent and independent mechanisms by increasing ribosome density
- (2017) Yuri V. Svitkin et al. NUCLEIC ACIDS RESEARCH
- Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
- (2017) Jesper Pallesen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis
- (2016) Alberto Fernández-Tejada et al. ACCOUNTS OF CHEMICAL RESEARCH
- Genomic Analysis of the Emergence, Evolution, and Spread of Human Respiratory RNA Viruses
- (2016) Tommy T.-Y. Lam et al. Annual Review of Genomics and Human Genetics
- mRNA capping: biological functions and applications
- (2016) Anand Ramanathan et al. NUCLEIC ACIDS RESEARCH
- DNA immunization as a technology platform for monoclonal antibody induction
- (2016) Shuying Liu et al. Emerging Microbes & Infections
- Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
- (2015) Andreas Thess et al. MOLECULAR THERAPY
- mRNA transcript therapy
- (2014) Drew Weissman Expert Review of Vaccines
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- The contribution of vaccination to global health: past, present and future
- (2014) B. Greenwood PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Rapid generation of a mouse model for Middle East respiratory syndrome
- (2014) Jincun Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Key roles of adjuvants in modern vaccines
- (2013) Steven G Reed et al. NATURE MEDICINE
- Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin
- (2012) B. Zakeri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA vaccines for targeting bacterial infections
- (2010) Mariana Ingolotti et al. Expert Review of Vaccines
- Endogenous toll-like receptor ligands and their biological significance
- (2010) Li Yu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Control of poly(A) tail length
- (2010) Christian R. Eckmann et al. Wiley Interdisciplinary Reviews-RNA
- Heterologous prime–boost vaccination
- (2009) Shan Lu CURRENT OPINION IN IMMUNOLOGY
- DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial
- (2009) Suzanne Jones et al. VACCINE
- Vaccination greatly reduces disease, disability, death and inequity worldwide
- (2008) FE Andre et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started